Thinking post-Paxlovid: Rutgers researchers eye the next generation of COVID drugs
Gothamist is a non-profit local newsroom, powered by WNYC.
Source: gothamist.com
Simcere Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Simcere Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Simcere Pharmaceutical Today - Breaking & Trending Today
China Increases Merger Filing Thresholds | Skadden, Arps, Slate, Meagher & Flom LLP
China has finally published the long-awaited amendments to its merger control filing thresholds, which will materially impact companies considering mergers, acquisitions and joint...
Source: jdsupra.com
The year in review – a close look at China's merger control since the amendment of the Anti-Monopoly Law | Hogan Lovells
Looking back on the year 2023, this alert aims to give an update on the state of play in Chinese merger control. In particular, it looks at how merger control has evolved since China’s...
Source: jdsupra.com
When Will New COVID-19 Antivirals Be Approved in the U.S.?
COVID-19 antivirals like simnotrelvir and ensitrelvir seem to work for more people than Paxlovid. But they're not approved in the U.S.
Source: time.com
Innovation and Investment Propel DNA Encoded Library Market: AI Integration and Strategic Alliances Fuel Remarkable Growth
/PRNewswire/ -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.com's offering....
Source: prnewswire.com